Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy (""RITE-CI"") for Pediatric Opsoclonus-Myoclonus Syndrome : Immunomarkers and Clinical Observations

DSpace Repository

Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy (""RITE-CI"") for Pediatric Opsoclonus-Myoclonus Syndrome : Immunomarkers and Clinical Observations

Author: Pranzatelli, Michael R.; Tate, Elizabeth D.; Alber, Michael; Awadalla, Maha; Blumkin, Lubov; Lina, Elena S.; Leiz, Steffen; Moser, Judit
Tübinger Autor(en):
Alber, Michael Wolfgang Hans-Peter
Published in: Neuropediatrics (2018), Bd. 49, H. 2, S. 123-134
Verlagsangabe: Georg Thieme Verlag KG
Language: English
Full text: http://dx.doi.org/10.1055/s-0037-1609038
ISSN: 1439-1899
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)